| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |